ADVI Health’s CEO, Marc Samuels, was recently featured in Endpoints News to discuss Robert F. Kennedy’s possible confirmation. In the article, The RFK question: Trump’s HHS nominee splits biopharma before moment of truth, Marc shared that he didn’t think RFK Jr. would remove FDA staff or ‘go into hysterics’ in terms of user fees.

Read more of Marc’s insights in Endpoints News.